BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25494641)

  • 1. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
    Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
    BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
    Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.
    Markkula J; Hemming-Harlo M; Salminen MT; Savolainen-Kopra C; Pirhonen J; Al-Hello H; Vesikari T
    Infect Dis (Lond); 2017 May; 49(5):388-395. PubMed ID: 28067093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland.
    Hemming-Harlo M; Markkula J; Huhti L; Salminen M; Vesikari T
    Pediatr Infect Dis J; 2016 Dec; 35(12):1304-1308. PubMed ID: 27455440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.
    Muhsen K; Rubenstein U; Kassem E; Goren S; Schachter Y; Kremer A; Shulman LM; Ephros M; Cohen D
    Hum Vaccin Immunother; 2015; 11(10):2475-82. PubMed ID: 26212174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
    Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.
    Hemming M; Räsänen S; Huhti L; Paloniemi M; Salminen M; Vesikari T
    Eur J Pediatr; 2013 Jun; 172(6):739-46. PubMed ID: 23361964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.
    Wilson SE; Rosella LC; Wang J; Le Saux N; Crowcroft NS; Harris T; Bolotin S; Deeks SL
    PLoS One; 2016; 11(5):e0154340. PubMed ID: 27168335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom.
    Marlow R; Muir P; Vipond B; Lyttle M; Trotter C; Finn A
    Euro Surveill; 2015; 20(48):30077. PubMed ID: 26675375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
    Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel.
    Muhsen K; Chodick G; Goren S; Anis E; Ziv-Baran T; Shalev V; Cohen D
    Euro Surveill; 2015; 20(42):. PubMed ID: 26538450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
    Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
    Leino T; Baum U; Scott P; Ollgren J; Salo H
    Vaccine; 2017 Oct; 35(42):5611-5617. PubMed ID: 28893475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
    Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination.
    Bucardo F; Reyes Y; Svensson L; Nordgren J
    PLoS One; 2014; 9(5):e98201. PubMed ID: 24849288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
    Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.